How FibroScan-Guided Care Reversed Grade 3 NAFLD

Patient Profile

Age	42 years
Gender	Male
Occupation	IT Professional (Senior Project Manager)
City	Pune
Presenting Complaint	Persistent fatigue, a dull dragging ache in the upper-right abdomen, and an incidental “bright liver” reported on a routine health-check ultrasound
Diagnosis	Grade 3 Non-Alcoholic Fatty Liver Disease (NAFLD) with early fibrosis
Duration of Issue	Symptoms for ~14 months; fatty changes likely present several years
Previous Treatments	Over-the-counter “liver detox” supplements and an unsupervised crash diet no structured medical management
Date of Procedure	September 2024 (baseline assessment); managed over 6 months
Outcome	Excellent regression to Grade 1 with normalised liver enzymes

The Problem

Condition

Non-alcoholic fatty liver disease is the build-up of excess fat inside liver cells in a person who drinks little or no alcohol. On ultrasound it is graded by severity, and this patient presented at Grade 3, the most advanced fatty grade, where the liver is heavily infiltrated with fat and the deeper vessel walls become difficult to visualise. In plain language, a healthy liver should look lean and uniform; this patient’s liver was diffusely enlarged, bright, and globally affected rather than patchy on one side. A FibroScan (transient elastography) confirmed not only a high fat score but also early stiffening of the liver tissue, signalling that fibrosis had begun the stage before scarring becomes permanent.

Emotional & Psychological Impact

For a 42-year-old running high-pressure IT delivery schedules, the diagnosis landed hard. He had assumed his exhaustion was simply overwork, and the word “liver” frightened him because a close relative had progressed to liver cirrhosis. For more than a year he had quietly cut back on social dinners, felt self-conscious about his expanding waistline, and lost confidence in his own health. He had tried internet “detox” supplements and a punishing crash diet that left him more fatigued and achieved nothing measurable. By the time he sought structured care, he was anxious, demotivated, and convinced the damage might already be irreversible — a fear that a clear, evidence-based plan would later relieve.

Consultation & Treatment Plan

What Was Assessed During the Consultation?

Detailed history confirming negligible alcohol intake, ruling out alcoholic liver disease and isolating the metabolic cause
Anthropometry and metabolic markers BMI 31.4, waist circumference, blood pressure, and a strong family history of type 2 diabetes
Liver function tests (ALT, AST, GGT), fasting glucose, HbA1c, and a full lipid profile to map the metabolic syndrome driving the fat
Abdominal ultrasound grading and a baseline FibroScan to quantify both fat (CAP) and stiffness (kPa) objectively
Patient goals reverse the condition without surgery, regain energy, and avoid the cirrhosis path he had seen in his family

Why This FibroScan-Guided Approach Was Chosen

Dr. Kothari selected a non-invasive, FibroScan-guided medical management pathway rather than relying on ultrasound alone or jumping to a liver biopsy. The reasoning:

FibroScan over biopsy for monitoring: transient elastography measures fat and fibrosis painlessly and can be repeated every few months to track regression objectively, sparing the patient an invasive procedure.
Targeting the root caus: because NAFLD here was driven by metabolic syndrome, the plan attacked insulin resistance and visceral fat directly through a structured, supervised lifestyle and pharmacological programme rather than ineffective “liver tonics.”
Staged, measurable goals: a target of 7–10% body-weight loss was set, the threshold shown to reverse steatosis and reduce inflammation, with FibroScan re-checks to confirm the liver was responding.
Early intervention before scarring: because fibrosis was early, prompt management offered a genuine window to reverse the disease and prevent progression to cirrhosis.

Baseline Imaging & Documentation

Baseline imaging documents the starting clinical condition and anchors the FibroScan-guided plan. Studies were performed in standardised, fasting conditions before treatment began.

Management Protocol:- Step by Step

Baseline FibroScan and bloods recorded to fix an objective starting point (CAP and kPa, ALT/AST/GGT, HbA1c, lipids)
Structured calorie-controlled, low-refined-carbohydrate Mediterranean-style diet designed with a target of 7–10% body-weight reduction
Graded exercise prescription 150 minutes/week of moderate activity plus twice-weekly resistance training to cut visceral fat
Insulin sensitisation and metabolic control evidence-based pharmacological support and vitamin E where indicated, with strict avoidance of hepatotoxic supplements
Complete elimination of alcohol and over-the-counter “detox” products, plus optimisation of lipids and blood pressure
Monthly clinical review with repeat liver enzymes to keep the patient accountable and adjust the plan
Interval FibroScan re-assessment at 3 and 6 months to confirm reduction in fat and stiffness

Management Facts

Programme Duration	6 months of supervised, FibroScan-guided management
Anaesthesia	None entirely non-invasive, no surgery or biopsy required
Key Diagnostic Tool	FibroScan / Transient Elastography CAP for fat, kPa for stiffness
Approach	Lifestyle modification + targeted metabolic therapy
Complications	None
Hospital Stay	Nil fully outpatient (OPD-based)

Post-Management Results

Over six months the patient lost roughly 9% of his body weight and his energy returned markedly. Repeat FibroScan showed the liver fat (CAP) and stiffness (kPa) had both fallen substantially, with ultrasound grading regressing from Grade 3 to Grade 1. Liver enzymes that had been elevated at baseline normalised completely confirming the disease had been reversed, not merely controlled.

Outcomes at a Glance

Outcome Metric	Result
Liver Fat (FibroScan CAP)	✔ Markedly reduced regression Grade 3 → Grade 1
Liver Stiffness (kPa)	✔ Improved early fibrosis no longer detectable
Liver Enzymes (ALT/AST/GGT)	✔ Fully normalised
Body Weight	✔ ~9% reduction within target range
Patient Satisfaction	✔ Very high renewed energy and confidence
Complications	✔ None

Ongoing Care & Maintenance

Instructions Given to Patient

Maintain the Mediterranean-style, low-refined-carbohydrate eating pattern as a permanent habit, not a temporary diet
Continue 150+ minutes of moderate exercise weekly with twice-weekly resistance training to preserve muscle and metabolic gains
Sustain weight within target and monitor waist circumference monthly
Strictly avoid alcohol and unverified herbal “liver detox” supplements
Keep HbA1c, lipids, and blood pressure controlled with prescribed medication and periodic review
Attend scheduled follow-ups, including an annual FibroScan to confirm the liver remains healthy

Recovery & Reversal Timeline

Timeframe	What the Patient Could Expect
Weeks 1–4	Adapting to the new diet and activity plan; early energy gains; first weight reduction
Month 2	Noticeable drop in fatigue; first repeat liver enzymes trending down
Month 3	Interval FibroScan shows measurable fall in fat score; ~5% weight lost
Month 6	Repeat FibroScan confirms Grade 3 → Grade 1 regression; enzymes normalised; ~9% weight lost
Ongoing	Annual FibroScan and metabolic review to maintain reversal and prevent recurrence

Patient Feedback

“Honestly, I came in terrified that I’d wrecked my liver for good. What helped most was seeing the actual FibroScan numbers improve every few months it kept me going. I have my energy back, I’ve lost the weight, and the team explained every step so it never felt like guesswork. I wish I’d come in a year earlier.”

Profile: Male · 42 years · IT Professional · Pune

Procedure: FibroScan-guided NAFLD management · Pune · September 2024 – March 2025

Surgeon: Dr. Ksheetij Kothari · Consultant Gastroenterologist

Disclaimer: The information shared in this content is for educational purposes only and not for promotional use.